Results 21 to 30 of about 4,771 (191)
RETRACTED ARTICLE: Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer [PDF]
Purpose Advanced thyroid cancer responds poorly to most therapies. New therapies and combinations are needed. The aim of this study was to examine both in vitro and in vivo activity of two relatively new histone deacetylase inhibitors (HDACIs ...
Daniel Chan +8 more
doaj +5 more sources
Angioimmunoblastic T‐cell lymphoma (AITL), a rare and aggressive subtype of peripheral T‐cell lymphoma (PTCL), often demonstrates resistance to standard therapies.
Vassiliki Labropoulou +6 more
doaj +2 more sources
Repurposing Belinostat for Alleviation of Atopic Dermatitis [PDF]
Atopic dermatitis (AD) is a highly prevalent chronic inflammatory skin disease that is characterized by intense pruritus, seriously affecting patients' quality of life. Its pathophysiology, which involves both the adaptive and innate immune responses as well as skin barrier defects, is still poorly understood. We recently identified a microRNA, miR-335,
Shan Quah +2 more
openaire +2 more sources
Purpose: The histone deacetylase inhibitor (HDACi), belinostat, has had limited therapeutic impact in solid tumors, such as colon cancer, due to its poor metabolic stability. Here we evaluated a novel belinostat prodrug, copper-bis-belinostat (Cubisbel),
Anna Blümel (7898387) +19 more
core +5 more sources
Drug Monographs: Belinostat and Idelalisib [PDF]
The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases ...
Whitney L, Piper +2 more
openaire +2 more sources
Apoptotic effect of Belinostat [PDF]
Aim: Breast cancer continues to be the most common type of cancer among women. Recent development in epigenomics has highlighted key mechanisms in which epigenetic regulation contributes to cancer treatment.
Eroglu Gunes, Canan +3 more
core +1 more source
Anticancer clinical efficiency and stochastic mechanisms of belinostat
Cancer progression is strongly affected by epigenetic events in addition to genetic modifications. One of the key elements in the epigenetic control of gene expression is histone modification through acetylation, which is regulated by the synergy between histone acetyltransferases (HATs) and histone deacetylases (HDACs).
Nasreddine El Omari +8 more
openaire +2 more sources
Background Treatment options for patients with recurrent superficial bladder cancer are limited, necessitating aggressive exploration of new treatment strategies that effectively prevent recurrence and progression to invasive disease.
Liebes Leonard +10 more
doaj +1 more source
Key Clinical Message This case report highlights the potential of belinostat for the treatment of relapsed/refractory peripheral T‐cell lymphomas, for which effective therapies are still scarce.
Vincent Camus +16 more
doaj +1 more source
Retraction Note: Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer [PDF]
Daniel Chan +8 more
doaj +2 more sources

